Immunic Inc’s recent filing unveils that its Executive Chairman Nash Duane acquired Company’s shares for reported $16694.0 on Jun 13 ’25. In the deal valued at $0.83 per share,20,000 shares were bought. As a result of this transaction, Nash Duane now holds 36,032 shares worth roughly $32428.8.
Then, Tardio Jason bought 12,512 shares, generating $9,884 in total proceeds. Upon buying the shares at $0.79, the President and COO now owns 12,512 shares.
Before that, Vitt Daniel bought 15,000 shares. Immunic Inc shares valued at $11,550 were divested by the CEO and Director at a price of $0.77 per share. As a result of the transaction, Vitt Daniel now holds 29,000 shares, worth roughly $26100.0.
Chardan Capital Markets initiated its Immunic Inc [IMUX] rating to a Buy in a research note published on September 29, 2025; the price target was $13. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late March with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering IMUX with “Buy” recommendation on November 25, 2024.
Price Performance Review of IMUX
On Friday, Immunic Inc [NASDAQ:IMUX] saw its stock fall -2.34% to $0.9. Over the last five days, the stock has lost -8.16%. Immunic Inc shares have fallen nearly -42.40% since the year began. Nevertheless, the stocks have fallen -10.15% over the past one year.
How much short interest is there in Immunic Inc?
A steep rise in short interest was recorded in Immunic Inc stocks on 2025-09-30, growing by 0.6 million shares to a total of 10.43 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 9.83 million shares. There was a rise of 5.76%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 27, 2024 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $6 price target.
